Doesn't really matter. We now know: "The die is cast."

Good work.

Also an important watch.

WITH THESE GREAT RESULTS THANK GOD WE HAVE VAN BIT TO HANDLE ALL THE GREAT PR THAT WILL NOW SEIZE THE DAY.

I BET HE IS WORKING ON THAT RIGHT NOW.

I was responding to your request for links to articles dealing with brain issues re VIP and COVID. I don't have enough specific knowledge of these interactions or Gabapentin to comment on your question. I do hope AVIPTADIL/ZYESAMI can substitute for Gabapentin since seems like that if it could it would do so with fewer side-effects.

If the news is good or spectacular it makes very good sense to be announcing it in the hour just before the market opens for the first day of the week.

More important , it is scheduled at 8:30am so if it is good news it comes out just before the market opens hopefully with a very big impact.

VAN BIT, COME ON NOW, ASTRAZENECA NEEDS YOUR PR HELP A LOT MORE THAN
RLFTF!!!!!!!!

WHO says most regions of the globe are seeing an increase in Covid cases as variants spread
New cases worldwide increased by 8% over the last week, the fifth week in a row that the WHO has seen an increase in transmission.

https://cnb.cx/3rk2TMZ

For one thing, AstraZeneca did a terrible PR job on their vaccine and obviously needs Van Bit's help on PR issues a lot more than RLFTF does.

Nice find.

VIP Modulation of Hippocampal Synaptic Plasticity: A Role for VIP Receptors as Therapeutic Targets in Cognitive Decline and Mesial Temporal Lobe Epilepsy

https://www.frontiersin.org/articles/10.3389/fncel.2020.00153/full

This extensive review of VIP at the 50th anniversary of its discovery says:

Vasoactive intestinal polypeptide plasma levels associated with affective symptoms and brain structure and function in healthy females

https://www.nature.com/articles/s41598-020-80873-2

Yes, if RLF had a full throated PR effort going, which Javitt says they won't have and won't need,
Van Bit would be doing his best to rip it apart.

I saw it live, George Mikan and Wilt Chamberlain with Rick Barry almost reviving it. But those weren't throws either. At best they were lobs.

FREE THE LOB 3

Why is it called a FreeThrow instead of a Free Shot? No one throws it.

Is it possible that Big Pharma is reticent about approval of an effective therapeutic in the midst of the vaccines roll out because it might make antivaxxers more comfortable with their decision to not vaccinate?

If so, could Relief Therapeutics counter that by indicating they would require a commitment from all patients treated with Zyesami to get vaccinated at the appropriate interval after successful treatment?

The buyer will be a strong hand as things develop.

I presume it is in part because the buyer thinks it is a good deal that will pay off very well and thus will
be a strong hand.

Where did you get your info from?

Where are you finding this information?

That's what I do. I hope you are touting a surprise.

Then why is volume very low?

Quote by Dr. Javitt:

I think the Zyesami, especially when used early, would greatly reduce the incidence and intensity of the effects faced by the so called "long-haulers."

Quote by Dr. Javitt:

Whatever the case, I think we can assume GEM is not opposed to making a lot of money.

OMG, mc67, has VanBit seen this statement bu Dr. Javitt:

Wow, JB, I am a bit surprised I actually beat you on posting this one by u/firebrand here. He does do a great job. Can you tell us his handle here?

You speculate but even you were right about everything it is a far cry from re FitBit:

If RLFTF hits $20 in the near future FitBit will be quick to point out that better PR leading up to the granting of the EUA would have had it at $200.

BRPA/NeuroRx & Relief Therapeutics (RLFTF) have demonstrated the 1st EFFECTIVE treatment for severe COVID 19 in today’s phase 3 results! There is MASSIVE Upside with CONFIRMED OWS stockpiling agreement and planned RLFTF NASDAQ uplisting, EUA/full FDA approval. This is the mother of all DD! TLDR

https://www.reddit.com/r/SPACs/comments/lqx2mc/brpaneurorx_relief_therapeutics_rlftf_have/

Swiss-Based Biotech Pops On Covid-19 Related Results
$RLFTF #Aviptadil #Zyesami

https://www.baystreet.ca/stockstowatch/9838/Swiss-Based-Biotech-Pops-On-Covid-19-Related-Results#.YDVuZPbXRKI.twitter

Comments and evaluations of this:

Key ivermectin study was a fraud
https://trialsitenews.com/key-ivermectin-study-was-a-fraud/

From 12/2/2020

Study: adding peptides to COVID-19 vaccines improves effectiveness for under-represented populations

https://www.csail.mit.edu/news/study-adding-peptides-covid-19-vaccines-improves-effectiveness-under-represented-populations

He also might be long RLFTF and interested in scrounging up a few more shares as cheaply as possible by everyday talking the sp down a bit.

Good points.